Astellas seeks US FDA approval for tacrolimus ER capsules pharmabiz.com Astellas Pharma US, Inc., a subsidiary of Tokyo-based Astellas Pharma Inc. has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) seeking approval for tacrolimus extended release capsules for the prophylaxis of organ ... Astellas Submits U.S. New Drug Application for Tacrolimus Extended Release ... Astellas seeks FDA approval for tacrolimus tablets |
